← Open Payments lookup

ISABELLA WASZKIEWICZ: Open Payments

NPI 1467084855 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,508 in 148 payments from 13 companies in 2025. Trend: 2023 $1,111 · 2024 $3,164 · 2025 $3,508

Food & beverage: $3,428Education: $80
CompanyPaymentsAmount
ABBVIE INC.41$655
Neurocrine BioSciences, Inc.18$608
Teva Pharmaceuticals USA, Inc.19$564
Alkermes, Inc.16$419
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)24$370
E.R. Squibb & Sons, L.L.C.6$294
Axsome Therapeutics, Inc.8$230
Janssen Pharmaceuticals, Inc5$115
Takeda Pharmaceuticals U.S.A., Inc.4$91
Bausch Health US, LLC3$67

Products named: VRAYLAR, INGREZZA, AUSTEDO XR, CAPLYTA, COBENFY, ARISTADA, Auvelity, LYBALVI.

Industry payments across AZ — which companies pay providers there.